nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—CYP3A5—Teniposide—lymphatic system cancer	0.114	0.155	CbGbCtD
Fluconazole—CYP2C19—Teniposide—lymphatic system cancer	0.0917	0.125	CbGbCtD
Fluconazole—CYP2C9—Teniposide—lymphatic system cancer	0.0762	0.104	CbGbCtD
Fluconazole—CYP3A7—Vincristine—lymphatic system cancer	0.0729	0.0995	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0729	0.0995	CbGbCtD
Fluconazole—CYP3A5—Vincristine—lymphatic system cancer	0.0547	0.0747	CbGbCtD
Fluconazole—ABCB1—Mitoxantrone—lymphatic system cancer	0.0517	0.0706	CbGbCtD
Fluconazole—CYP3A4—Cytarabine—lymphatic system cancer	0.045	0.0614	CbGbCtD
Fluconazole—CYP3A4—Teniposide—lymphatic system cancer	0.0443	0.0605	CbGbCtD
Fluconazole—ABCB1—Vincristine—lymphatic system cancer	0.0356	0.0486	CbGbCtD
Fluconazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.031	0.0423	CbGbCtD
Fluconazole—ABCB1—Methotrexate—lymphatic system cancer	0.0215	0.0294	CbGbCtD
Fluconazole—CYP3A4—Vincristine—lymphatic system cancer	0.0213	0.0291	CbGbCtD
Fluconazole—Alopecia—Bleomycin—lymphatic system cancer	0.000679	0.00254	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000679	0.00254	CcSEcCtD
Fluconazole—Jaundice—Mitoxantrone—lymphatic system cancer	0.000677	0.00253	CcSEcCtD
Fluconazole—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000677	0.00253	CcSEcCtD
Fluconazole—Urticaria—Teniposide—lymphatic system cancer	0.000673	0.00252	CcSEcCtD
Fluconazole—Herpes simplex—Methotrexate—lymphatic system cancer	0.000672	0.00251	CcSEcCtD
Fluconazole—Abdominal pain—Teniposide—lymphatic system cancer	0.00067	0.0025	CcSEcCtD
Fluconazole—Body temperature increased—Teniposide—lymphatic system cancer	0.00067	0.0025	CcSEcCtD
Fluconazole—Paraesthesia—Fludarabine—lymphatic system cancer	0.000669	0.0025	CcSEcCtD
Fluconazole—Hallucination—Carmustine—lymphatic system cancer	0.000668	0.0025	CcSEcCtD
Fluconazole—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000659	0.00246	CcSEcCtD
Fluconazole—Dyspepsia—Fludarabine—lymphatic system cancer	0.000656	0.00245	CcSEcCtD
Fluconazole—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000648	0.00242	CcSEcCtD
Fluconazole—Decreased appetite—Fludarabine—lymphatic system cancer	0.000647	0.00242	CcSEcCtD
Fluconazole—Visual impairment—Carmustine—lymphatic system cancer	0.000647	0.00242	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000643	0.0024	CcSEcCtD
Fluconazole—Fatigue—Fludarabine—lymphatic system cancer	0.000642	0.0024	CcSEcCtD
Fluconazole—Hallucination—Vincristine—lymphatic system cancer	0.000637	0.00238	CcSEcCtD
Fluconazole—Pain—Fludarabine—lymphatic system cancer	0.000637	0.00238	CcSEcCtD
Fluconazole—Constipation—Fludarabine—lymphatic system cancer	0.000637	0.00238	CcSEcCtD
Fluconazole—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000633	0.00236	CcSEcCtD
Fluconazole—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000629	0.00235	CcSEcCtD
Fluconazole—Urethral disorder—Vincristine—lymphatic system cancer	0.000628	0.00235	CcSEcCtD
Fluconazole—Eye disorder—Carmustine—lymphatic system cancer	0.000627	0.00234	CcSEcCtD
Fluconazole—Hypersensitivity—Teniposide—lymphatic system cancer	0.000624	0.00233	CcSEcCtD
Fluconazole—Flushing—Carmustine—lymphatic system cancer	0.000623	0.00233	CcSEcCtD
Fluconazole—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000621	0.00232	CcSEcCtD
Fluconazole—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000619	0.00231	CcSEcCtD
Fluconazole—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000619	0.00231	CcSEcCtD
Fluconazole—Anaemia—Bleomycin—lymphatic system cancer	0.000618	0.00231	CcSEcCtD
Fluconazole—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000614	0.00229	CcSEcCtD
Fluconazole—Asthenia—Teniposide—lymphatic system cancer	0.000608	0.00227	CcSEcCtD
Fluconazole—Malaise—Bleomycin—lymphatic system cancer	0.000603	0.00226	CcSEcCtD
Fluconazole—Pruritus—Teniposide—lymphatic system cancer	0.0006	0.00224	CcSEcCtD
Fluconazole—Leukopenia—Bleomycin—lymphatic system cancer	0.000599	0.00224	CcSEcCtD
Fluconazole—Cardiac disorder—Vincristine—lymphatic system cancer	0.000594	0.00222	CcSEcCtD
Fluconazole—Alopecia—Carmustine—lymphatic system cancer	0.000593	0.00222	CcSEcCtD
Fluconazole—Body temperature increased—Fludarabine—lymphatic system cancer	0.000589	0.0022	CcSEcCtD
Fluconazole—Mental disorder—Carmustine—lymphatic system cancer	0.000588	0.0022	CcSEcCtD
Fluconazole—Vaginal infection—Methotrexate—lymphatic system cancer	0.000584	0.00218	CcSEcCtD
Fluconazole—Malnutrition—Carmustine—lymphatic system cancer	0.000584	0.00218	CcSEcCtD
Fluconazole—Angiopathy—Vincristine—lymphatic system cancer	0.000581	0.00217	CcSEcCtD
Fluconazole—Diarrhoea—Teniposide—lymphatic system cancer	0.00058	0.00217	CcSEcCtD
Fluconazole—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000577	0.00216	CcSEcCtD
Fluconazole—Myalgia—Bleomycin—lymphatic system cancer	0.00057	0.00213	CcSEcCtD
Fluconazole—Alopecia—Vincristine—lymphatic system cancer	0.000566	0.00212	CcSEcCtD
Fluconazole—Back pain—Carmustine—lymphatic system cancer	0.000565	0.00211	CcSEcCtD
Fluconazole—Discomfort—Bleomycin—lymphatic system cancer	0.000563	0.0021	CcSEcCtD
Fluconazole—Mental disorder—Vincristine—lymphatic system cancer	0.000561	0.0021	CcSEcCtD
Fluconazole—Chills—Mitoxantrone—lymphatic system cancer	0.00056	0.00209	CcSEcCtD
Fluconazole—Urine output increased—Methotrexate—lymphatic system cancer	0.00056	0.00209	CcSEcCtD
Fluconazole—Alopecia—Mitoxantrone—lymphatic system cancer	0.000551	0.00206	CcSEcCtD
Fluconazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000549	0.00205	CcSEcCtD
Fluconazole—Tremor—Carmustine—lymphatic system cancer	0.000547	0.00205	CcSEcCtD
Fluconazole—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000546	0.00204	CcSEcCtD
Fluconazole—Anaemia—Carmustine—lymphatic system cancer	0.00054	0.00202	CcSEcCtD
Fluconazole—Back pain—Vincristine—lymphatic system cancer	0.000539	0.00202	CcSEcCtD
Fluconazole—Vomiting—Teniposide—lymphatic system cancer	0.000539	0.00201	CcSEcCtD
Fluconazole—Sepsis—Methotrexate—lymphatic system cancer	0.000537	0.00201	CcSEcCtD
Fluconazole—Agitation—Carmustine—lymphatic system cancer	0.000537	0.00201	CcSEcCtD
Fluconazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000535	0.002	CcSEcCtD
Fluconazole—Asthenia—Fludarabine—lymphatic system cancer	0.000534	0.002	CcSEcCtD
Fluconazole—Rash—Teniposide—lymphatic system cancer	0.000534	0.002	CcSEcCtD
Fluconazole—Dermatitis—Teniposide—lymphatic system cancer	0.000534	0.002	CcSEcCtD
Fluconazole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000532	0.00199	CcSEcCtD
Fluconazole—Headache—Teniposide—lymphatic system cancer	0.000531	0.00198	CcSEcCtD
Fluconazole—Pruritus—Fludarabine—lymphatic system cancer	0.000527	0.00197	CcSEcCtD
Fluconazole—Back pain—Mitoxantrone—lymphatic system cancer	0.000525	0.00196	CcSEcCtD
Fluconazole—Leukopenia—Carmustine—lymphatic system cancer	0.000523	0.00195	CcSEcCtD
Fluconazole—Anorexia—Bleomycin—lymphatic system cancer	0.000521	0.00195	CcSEcCtD
Fluconazole—Anaemia—Vincristine—lymphatic system cancer	0.000515	0.00193	CcSEcCtD
Fluconazole—Agitation—Vincristine—lymphatic system cancer	0.000512	0.00192	CcSEcCtD
Fluconazole—Polyuria—Methotrexate—lymphatic system cancer	0.000512	0.00191	CcSEcCtD
Fluconazole—Diarrhoea—Fludarabine—lymphatic system cancer	0.00051	0.0019	CcSEcCtD
Fluconazole—Convulsion—Carmustine—lymphatic system cancer	0.000506	0.00189	CcSEcCtD
Fluconazole—Hypertension—Carmustine—lymphatic system cancer	0.000504	0.00189	CcSEcCtD
Fluconazole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000504	0.00188	CcSEcCtD
Fluconazole—Nausea—Teniposide—lymphatic system cancer	0.000503	0.00188	CcSEcCtD
Fluconazole—Anaemia—Mitoxantrone—lymphatic system cancer	0.000502	0.00188	CcSEcCtD
Fluconazole—Vertigo—Vincristine—lymphatic system cancer	0.000501	0.00187	CcSEcCtD
Fluconazole—Hepatic failure—Methotrexate—lymphatic system cancer	0.0005	0.00187	CcSEcCtD
Fluconazole—Leukopenia—Vincristine—lymphatic system cancer	0.000499	0.00187	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000498	0.00186	CcSEcCtD
Fluconazole—Myalgia—Carmustine—lymphatic system cancer	0.000497	0.00186	CcSEcCtD
Fluconazole—Paraesthesia—Bleomycin—lymphatic system cancer	0.00049	0.00183	CcSEcCtD
Fluconazole—Malaise—Mitoxantrone—lymphatic system cancer	0.00049	0.00183	CcSEcCtD
Fluconazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000486	0.00182	CcSEcCtD
Fluconazole—Convulsion—Vincristine—lymphatic system cancer	0.000483	0.00181	CcSEcCtD
Fluconazole—Hypertension—Vincristine—lymphatic system cancer	0.000481	0.0018	CcSEcCtD
Fluconazole—Decreased appetite—Bleomycin—lymphatic system cancer	0.000475	0.00177	CcSEcCtD
Fluconazole—Myalgia—Vincristine—lymphatic system cancer	0.000475	0.00177	CcSEcCtD
Fluconazole—Vomiting—Fludarabine—lymphatic system cancer	0.000474	0.00177	CcSEcCtD
Fluconazole—Convulsion—Mitoxantrone—lymphatic system cancer	0.00047	0.00176	CcSEcCtD
Fluconazole—Rash—Fludarabine—lymphatic system cancer	0.00047	0.00176	CcSEcCtD
Fluconazole—Dermatitis—Fludarabine—lymphatic system cancer	0.000469	0.00175	CcSEcCtD
Fluconazole—Hypertension—Mitoxantrone—lymphatic system cancer	0.000469	0.00175	CcSEcCtD
Fluconazole—Pain—Bleomycin—lymphatic system cancer	0.000467	0.00175	CcSEcCtD
Fluconazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000467	0.00174	CcSEcCtD
Fluconazole—Headache—Fludarabine—lymphatic system cancer	0.000467	0.00174	CcSEcCtD
Fluconazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.000462	0.00173	CcSEcCtD
Fluconazole—Discomfort—Mitoxantrone—lymphatic system cancer	0.000457	0.00171	CcSEcCtD
Fluconazole—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000455	0.0017	CcSEcCtD
Fluconazole—Anorexia—Carmustine—lymphatic system cancer	0.000454	0.0017	CcSEcCtD
Fluconazole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00045	0.00168	CcSEcCtD
Fluconazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.000446	0.00167	CcSEcCtD
Fluconazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000446	0.00167	CcSEcCtD
Fluconazole—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000443	0.00166	CcSEcCtD
Fluconazole—Nausea—Fludarabine—lymphatic system cancer	0.000442	0.00165	CcSEcCtD
Fluconazole—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00044	0.00164	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000434	0.00162	CcSEcCtD
Fluconazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000434	0.00162	CcSEcCtD
Fluconazole—Urticaria—Bleomycin—lymphatic system cancer	0.000434	0.00162	CcSEcCtD
Fluconazole—Anorexia—Vincristine—lymphatic system cancer	0.000434	0.00162	CcSEcCtD
Fluconazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.000432	0.00161	CcSEcCtD
Fluconazole—Insomnia—Carmustine—lymphatic system cancer	0.000431	0.00161	CcSEcCtD
Fluconazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00043	0.00161	CcSEcCtD
Fluconazole—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000428	0.0016	CcSEcCtD
Fluconazole—Paraesthesia—Carmustine—lymphatic system cancer	0.000428	0.0016	CcSEcCtD
Fluconazole—Somnolence—Carmustine—lymphatic system cancer	0.000424	0.00158	CcSEcCtD
Fluconazole—Anorexia—Mitoxantrone—lymphatic system cancer	0.000422	0.00158	CcSEcCtD
Fluconazole—Ataxia—Methotrexate—lymphatic system cancer	0.000422	0.00158	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000415	0.00155	CcSEcCtD
Fluconazole—Decreased appetite—Carmustine—lymphatic system cancer	0.000414	0.00155	CcSEcCtD
Fluconazole—Insomnia—Vincristine—lymphatic system cancer	0.000412	0.00154	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000412	0.00154	CcSEcCtD
Fluconazole—Paraesthesia—Vincristine—lymphatic system cancer	0.000409	0.00153	CcSEcCtD
Fluconazole—Constipation—Carmustine—lymphatic system cancer	0.000408	0.00152	CcSEcCtD
Fluconazole—Pain—Carmustine—lymphatic system cancer	0.000408	0.00152	CcSEcCtD
Fluconazole—Breast disorder—Methotrexate—lymphatic system cancer	0.000406	0.00152	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000405	0.00151	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000404	0.00151	CcSEcCtD
Fluconazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000402	0.0015	CcSEcCtD
Fluconazole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000398	0.00149	CcSEcCtD
Fluconazole—Decreased appetite—Vincristine—lymphatic system cancer	0.000396	0.00148	CcSEcCtD
Fluconazole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000394	0.00147	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000393	0.00147	CcSEcCtD
Fluconazole—Feeling abnormal—Carmustine—lymphatic system cancer	0.000393	0.00147	CcSEcCtD
Fluconazole—Fatigue—Vincristine—lymphatic system cancer	0.000392	0.00147	CcSEcCtD
Fluconazole—Asthenia—Bleomycin—lymphatic system cancer	0.000392	0.00146	CcSEcCtD
Fluconazole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00039	0.00146	CcSEcCtD
Fluconazole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00039	0.00146	CcSEcCtD
Fluconazole—Pain—Vincristine—lymphatic system cancer	0.000389	0.00145	CcSEcCtD
Fluconazole—Constipation—Vincristine—lymphatic system cancer	0.000389	0.00145	CcSEcCtD
Fluconazole—Pruritus—Bleomycin—lymphatic system cancer	0.000386	0.00144	CcSEcCtD
Fluconazole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000385	0.00144	CcSEcCtD
Fluconazole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000382	0.00143	CcSEcCtD
Fluconazole—Pain—Mitoxantrone—lymphatic system cancer	0.000379	0.00142	CcSEcCtD
Fluconazole—Constipation—Mitoxantrone—lymphatic system cancer	0.000379	0.00142	CcSEcCtD
Fluconazole—Body temperature increased—Carmustine—lymphatic system cancer	0.000377	0.00141	CcSEcCtD
Fluconazole—Abdominal pain—Carmustine—lymphatic system cancer	0.000377	0.00141	CcSEcCtD
Fluconazole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000372	0.00139	CcSEcCtD
Fluconazole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000365	0.00137	CcSEcCtD
Fluconazole—Neutropenia—Methotrexate—lymphatic system cancer	0.000363	0.00136	CcSEcCtD
Fluconazole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000362	0.00135	CcSEcCtD
Fluconazole—Body temperature increased—Vincristine—lymphatic system cancer	0.00036	0.00134	CcSEcCtD
Fluconazole—Abdominal pain—Vincristine—lymphatic system cancer	0.00036	0.00134	CcSEcCtD
Fluconazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000352	0.00132	CcSEcCtD
Fluconazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000351	0.00131	CcSEcCtD
Fluconazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00035	0.00131	CcSEcCtD
Fluconazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00035	0.00131	CcSEcCtD
Fluconazole—Vomiting—Bleomycin—lymphatic system cancer	0.000347	0.0013	CcSEcCtD
Fluconazole—Infestation NOS—Methotrexate—lymphatic system cancer	0.000346	0.00129	CcSEcCtD
Fluconazole—Infestation—Methotrexate—lymphatic system cancer	0.000346	0.00129	CcSEcCtD
Fluconazole—Rash—Bleomycin—lymphatic system cancer	0.000344	0.00129	CcSEcCtD
Fluconazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000344	0.00129	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000343	0.00128	CcSEcCtD
Fluconazole—Asthenia—Carmustine—lymphatic system cancer	0.000342	0.00128	CcSEcCtD
Fluconazole—Stomatitis—Methotrexate—lymphatic system cancer	0.000337	0.00126	CcSEcCtD
Fluconazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000335	0.00125	CcSEcCtD
Fluconazole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000327	0.00122	CcSEcCtD
Fluconazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000327	0.00122	CcSEcCtD
Fluconazole—Asthenia—Vincristine—lymphatic system cancer	0.000326	0.00122	CcSEcCtD
Fluconazole—Diarrhoea—Carmustine—lymphatic system cancer	0.000326	0.00122	CcSEcCtD
Fluconazole—Nausea—Bleomycin—lymphatic system cancer	0.000324	0.00121	CcSEcCtD
Fluconazole—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000323	0.00121	CcSEcCtD
Fluconazole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000318	0.00119	CcSEcCtD
Fluconazole—Dizziness—Carmustine—lymphatic system cancer	0.000315	0.00118	CcSEcCtD
Fluconazole—Diarrhoea—Vincristine—lymphatic system cancer	0.000311	0.00116	CcSEcCtD
Fluconazole—Pharyngitis—Methotrexate—lymphatic system cancer	0.000308	0.00115	CcSEcCtD
Fluconazole—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000307	0.00115	CcSEcCtD
Fluconazole—Urethral disorder—Methotrexate—lymphatic system cancer	0.000305	0.00114	CcSEcCtD
Fluconazole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000303	0.00113	CcSEcCtD
Fluconazole—Vomiting—Carmustine—lymphatic system cancer	0.000303	0.00113	CcSEcCtD
Fluconazole—Dizziness—Vincristine—lymphatic system cancer	0.000301	0.00112	CcSEcCtD
Fluconazole—Rash—Carmustine—lymphatic system cancer	0.000301	0.00112	CcSEcCtD
Fluconazole—Dermatitis—Carmustine—lymphatic system cancer	0.0003	0.00112	CcSEcCtD
Fluconazole—Visual impairment—Methotrexate—lymphatic system cancer	0.0003	0.00112	CcSEcCtD
Fluconazole—Headache—Carmustine—lymphatic system cancer	0.000299	0.00112	CcSEcCtD
Fluconazole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000294	0.0011	CcSEcCtD
Fluconazole—Eye disorder—Methotrexate—lymphatic system cancer	0.00029	0.00109	CcSEcCtD
Fluconazole—Vomiting—Vincristine—lymphatic system cancer	0.000289	0.00108	CcSEcCtD
Fluconazole—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000288	0.00108	CcSEcCtD
Fluconazole—Rash—Vincristine—lymphatic system cancer	0.000287	0.00107	CcSEcCtD
Fluconazole—Dermatitis—Vincristine—lymphatic system cancer	0.000287	0.00107	CcSEcCtD
Fluconazole—Headache—Vincristine—lymphatic system cancer	0.000285	0.00107	CcSEcCtD
Fluconazole—Nausea—Carmustine—lymphatic system cancer	0.000283	0.00106	CcSEcCtD
Fluconazole—Angiopathy—Methotrexate—lymphatic system cancer	0.000282	0.00105	CcSEcCtD
Fluconazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000282	0.00105	CcSEcCtD
Fluconazole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000281	0.00105	CcSEcCtD
Fluconazole—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00028	0.00105	CcSEcCtD
Fluconazole—Rash—Mitoxantrone—lymphatic system cancer	0.000279	0.00104	CcSEcCtD
Fluconazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000279	0.00104	CcSEcCtD
Fluconazole—Chills—Methotrexate—lymphatic system cancer	0.000279	0.00104	CcSEcCtD
Fluconazole—Headache—Mitoxantrone—lymphatic system cancer	0.000278	0.00104	CcSEcCtD
Fluconazole—Alopecia—Methotrexate—lymphatic system cancer	0.000275	0.00103	CcSEcCtD
Fluconazole—Mental disorder—Methotrexate—lymphatic system cancer	0.000272	0.00102	CcSEcCtD
Fluconazole—Malnutrition—Methotrexate—lymphatic system cancer	0.000271	0.00101	CcSEcCtD
Fluconazole—Nausea—Vincristine—lymphatic system cancer	0.00027	0.00101	CcSEcCtD
Fluconazole—Dysgeusia—Methotrexate—lymphatic system cancer	0.000265	0.00099	CcSEcCtD
Fluconazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000263	0.000984	CcSEcCtD
Fluconazole—Back pain—Methotrexate—lymphatic system cancer	0.000262	0.000978	CcSEcCtD
Fluconazole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000251	0.000938	CcSEcCtD
Fluconazole—Anaemia—Methotrexate—lymphatic system cancer	0.00025	0.000935	CcSEcCtD
Fluconazole—Malaise—Methotrexate—lymphatic system cancer	0.000244	0.000912	CcSEcCtD
Fluconazole—Vertigo—Methotrexate—lymphatic system cancer	0.000243	0.000909	CcSEcCtD
Fluconazole—Leukopenia—Methotrexate—lymphatic system cancer	0.000242	0.000905	CcSEcCtD
Fluconazole—Convulsion—Methotrexate—lymphatic system cancer	0.000234	0.000876	CcSEcCtD
Fluconazole—Myalgia—Methotrexate—lymphatic system cancer	0.00023	0.000861	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000229	0.000855	CcSEcCtD
Fluconazole—Discomfort—Methotrexate—lymphatic system cancer	0.000228	0.000851	CcSEcCtD
Fluconazole—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000221	0.000825	CcSEcCtD
Fluconazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000217	0.000809	CcSEcCtD
Fluconazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000216	0.000808	CcSEcCtD
Fluconazole—Skin disorder—Methotrexate—lymphatic system cancer	0.000214	0.000802	CcSEcCtD
Fluconazole—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000213	0.000798	CcSEcCtD
Fluconazole—Anorexia—Methotrexate—lymphatic system cancer	0.00021	0.000787	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000201	0.000752	CcSEcCtD
Fluconazole—Insomnia—Methotrexate—lymphatic system cancer	0.0002	0.000747	CcSEcCtD
Fluconazole—Paraesthesia—Methotrexate—lymphatic system cancer	0.000198	0.000741	CcSEcCtD
Fluconazole—Somnolence—Methotrexate—lymphatic system cancer	0.000196	0.000734	CcSEcCtD
Fluconazole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000194	0.000727	CcSEcCtD
Fluconazole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000192	0.000717	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000191	0.000713	CcSEcCtD
Fluconazole—Fatigue—Methotrexate—lymphatic system cancer	0.00019	0.000712	CcSEcCtD
Fluconazole—Pain—Methotrexate—lymphatic system cancer	0.000189	0.000706	CcSEcCtD
Fluconazole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000182	0.00068	CcSEcCtD
Fluconazole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000181	0.000675	CcSEcCtD
Fluconazole—Urticaria—Methotrexate—lymphatic system cancer	0.000175	0.000656	CcSEcCtD
Fluconazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000175	0.000652	CcSEcCtD
Fluconazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.000175	0.000652	CcSEcCtD
Fluconazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000163	0.000608	CcSEcCtD
Fluconazole—Asthenia—Methotrexate—lymphatic system cancer	0.000158	0.000592	CcSEcCtD
Fluconazole—Pruritus—Methotrexate—lymphatic system cancer	0.000156	0.000584	CcSEcCtD
Fluconazole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000151	0.000565	CcSEcCtD
Fluconazole—Dizziness—Methotrexate—lymphatic system cancer	0.000146	0.000546	CcSEcCtD
Fluconazole—Vomiting—Methotrexate—lymphatic system cancer	0.00014	0.000525	CcSEcCtD
Fluconazole—Rash—Methotrexate—lymphatic system cancer	0.000139	0.00052	CcSEcCtD
Fluconazole—Dermatitis—Methotrexate—lymphatic system cancer	0.000139	0.00052	CcSEcCtD
Fluconazole—Headache—Methotrexate—lymphatic system cancer	0.000138	0.000517	CcSEcCtD
Fluconazole—Nausea—Methotrexate—lymphatic system cancer	0.000131	0.00049	CcSEcCtD
